Rega marang bathi mangsa ngarep: Sarepta Therapeutics (SRPT)

Sarepta Corp - logo grafis emiten SRPT

Will the risks of failed tests and therapy payment complexities impact capitalization? The forward P/E multiple of the business provides the answer, with the current value standing at 156.50. Sarepta Therapeutics, Inc. (SRPT) leads the treatment of Duchenne muscular dystrophy, leveraging its status as an industry pioneer. High customer loyalty ensures a steady cash flow, completely eliminating the probability of a funding shortfall.

sarepta.com - Rasio kapitalisasi marang bathi mangsa ngarep SRPT (periode 04.07.2022 - 18.11.2026)

Rincian metrik keuangan lan pasar Sarepta (SRPT)

- indikator kapitalisasi bursa perusahaan:
Ringkesan analisis perusahaan:Sarepta Therapeutics Inc
Sampel barang sarepta.com

Forward P/E determines business value through the ratio of the current share price to the projected earnings per share for the year. By analyzing the expected P/E multiple of a company, an investor identifies the extent of the premium paid for future earnings. The calculation is based on analysts' consensus forecasts for net income. For Sarepta Therapeutics, Inc. (SRPT), this indicator reflects market confidence in the commercialization of gene therapy. High values here are justified by unique patents and strict FDA control.

Pesaing langsung

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|twistbioscience.com (TWST) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E TXG|NTLA (Intellia) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Stoke STOK|BioLife (BLFS) - Rasio prakiraan rega marang bathi|wavelifesciences.com - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake MAZE|SION: Pangali Forward P/E|PRME - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TSHA|QURE - Pangali forward rega marang bathi|Pangali Forward P/E MGTX|Kapitalisasi marang proyeksi bathi regenxbio.com|Pangali Forward P/E SLDB (Solid Biosciences Inc)|OCGN: Rasio rega marang bathi mangsa ngarep|PACB - Rega marang bathi mangsa ngarep|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E